Funding Award Will Improve Testing of Cancer Therapies

Hatim Sabaawy, MD, PhD explains why a key initial funding award is the first step in the fulfillment of a mission. The project focuses on immunotherapies for non-small cell lung cancer (NSCLC), which represents about 80% to 85% of all diagnosed lung cancers. About 350 people in the United States die from lung cancer each day, mostly from NSCLC.

Virginia Borges, MD, Discusses Advances in Breast Cancer

For 20 years, Dr. Borges has led the CU Cancer Center’s Young Women’s Breast Cancer Translational Program, and provides insight as to why breast cancer in younger women and in the first 5 to 10 years after pregnancy often are more aggressive than other breast cancers.

Wells Messersmith, MD, Distinguished Faculty Honoree

The Distinguished Faculty Professionalism Award recognizes faculty who consistently demonstrate exemplary professional behaviors, providing service to the community, demonstrating dedication to lifelong learning, and who contribute to the teaching, service, and administrative activities of their department and the CU School of Medicine.

How Dr. Lieu's Research Helps Fuel His Clinical Care

When asked about his philosophy in caring for patients, Dr. Lieu describes three pillars: Providing compassionate care, cutting edge care, and multidisciplinary care. And always understand that the patient is your responsibility.